share_log

Is Now The Time To Buy Stock Or Options In Blink Charging, Xpeng Or Palantir?

Is Now The Time To Buy Stock Or Options In Blink Charging, Xpeng Or Palantir?

現在是購買股票或閃電期權的時候了嗎,Xpeng還是Palantir?
Benzinga Real-time News ·  2021/04/02 02:02

One of the most common questions traders have about stocks is “Why Is It Moving?”

交易員對股市最常見的疑問之一是“為什麼它在動?”

That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.

這就是為什麼Benzinga在Benzinga Pro中創建了為什麼它在移動,或WIIM功能的原因。WIIM是對該股走勢的一句話描述。

Here’s the latest news and updates for Blink Charging, Xpeng and Palantir.

以下是Blink Charge、Xpeng和Palantir的最新消息和更新。

Blink Charging Co (NASDAQ:BLNK) shares are trading higher by 4% after the company announced it has deployed electric vehicle stations in Chile.

Blink Charge Co(納斯達克股票代碼:BLNK)宣佈在智利部署電動汽車加油站後,該公司股價上漲了4%。

Blink says the municipality of Pedro Aguirre Cerda carried out the first installation of Blink HQ 100 chargers by Electro Chile. The charging stations are located in the Consistorial Bicentenario building.

布林克説,佩德羅·阿吉雷·塞爾達市政府首次安裝了智利電力公司的布林克HQ 100充電器。充電站位於比森特納裏奧大廈的Consistorial Bicentenario。

Xpeng Inc - ADR (NYSE:XPEV) shares are trading higher by 2% after the company reported March vehicle deliveries, which increased 384% YoY and 130% from February.

Xpeng Inc-ADR(紐約證券交易所股票代碼:XPEV)股價上漲2%,此前該公司公佈3月份汽車交貨量同比增長384%,比2月份增長130%。

Both Chinese electric vehicle stocks NIO Limited (NYSE:NIO) and XPeng Inc. (NYSE:XPEV) redeemed themselves credibly in March after a softer February, reporting record first-quarter deliveries… Read More

中國電動汽車股票NIO有限公司(紐約證券交易所代碼:NIO)和新鵬公司(紐約證券交易所代碼:XPEV)在經歷了2月份的疲軟之後,在3月份進行了可信的贖回,報告了創紀錄的第一季度交貨量…多讀

Palantir Technologies Inc (NYSE:PLTR) Thursday issued additional details about the Palantir Foundry capabilities it will be highlighting in its Life Sciences demo at their "Double Click" event on April 14 at 11 a.m. ET.

亞洲網加利福尼亞州聖何塞4月14日電Palantir Technologies Inc(紐約證券交易所市場代碼:PLTR)週四發佈了有關Palantir Foundry功能的更多細節,該公司將在4月14日上午11點舉行的“雙擊”活動的生命科學演示中重點介紹Palantir Foundry的功能。埃特。

According to Palantir, their customers in Life Sciences span pharmaceuticals, research institutions, healthcare systems, and others. These customers rely on Foundry's secure and collaborative architecture to discover and develop drugs, manage commercial launches, conduct clinical research, and distribute vaccines.

根據Palantir的説法,他們在生命科學領域的客户涵蓋製藥、研究機構、醫療保健系統和其他領域。這些客户依賴Foundry的安全和協作架構來發現和開發藥物、管理商業投放、進行臨牀研究和分發疫苗。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論